Standard
Ropeginterferon Alfa-2b : Efficacy and Safety in Different Age Groups. / Gisslinger, Heinz; Klade, Christoph; Georgiev, Pencho; Krochmalczyk, Dorota; Gercheva-kyuchukova, Liana; Egyed, Miklos; Rossiev, Viktor; Dulicek, Petr; Illes, Arpad; Pylypenko, Halyna; Sivcheva, Lylia; Mayer, Jiri; Yablokova, Vera; Krejcy, Kurt; Hasselbalch, Hans C.; Kralovics, Robert; Kiladjian, Jean-jacques.
I:
HemaSphere, Bind 4, Nr. 6, e485, 2020.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Gisslinger, H, Klade, C, Georgiev, P, Krochmalczyk, D, Gercheva-kyuchukova, L, Egyed, M, Rossiev, V, Dulicek, P, Illes, A, Pylypenko, H, Sivcheva, L, Mayer, J, Yablokova, V, Krejcy, K
, Hasselbalch, HC, Kralovics, R & Kiladjian, J 2020, '
Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups',
HemaSphere, bind 4, nr. 6, e485.
https://doi.org/10.1097/HS9.0000000000000485APA
Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva-kyuchukova, L., Egyed, M., Rossiev, V., Dulicek, P., Illes, A., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Krejcy, K.
, Hasselbalch, H. C., Kralovics, R., & Kiladjian, J. (2020).
Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups.
HemaSphere,
4(6), [e485].
https://doi.org/10.1097/HS9.0000000000000485Vancouver
Gisslinger H, Klade C, Georgiev P, Krochmalczyk D, Gercheva-kyuchukova L, Egyed M o.a.
Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups.
HemaSphere. 2020;4(6). e485.
https://doi.org/10.1097/HS9.0000000000000485Author
Gisslinger, Heinz ; Klade, Christoph ; Georgiev, Pencho ; Krochmalczyk, Dorota ; Gercheva-kyuchukova, Liana ; Egyed, Miklos ; Rossiev, Viktor ; Dulicek, Petr ; Illes, Arpad ; Pylypenko, Halyna ; Sivcheva, Lylia ; Mayer, Jiri ; Yablokova, Vera ; Krejcy, Kurt ; Hasselbalch, Hans C. ; Kralovics, Robert ; Kiladjian, Jean-jacques. / Ropeginterferon Alfa-2b : Efficacy and Safety in Different Age Groups. I: HemaSphere. 2020 ; Bind 4, Nr. 6.
Bibtex
@article{bae51e7cc50c4dadbeec599272b7d191,
title = "Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups",
author = "Heinz Gisslinger and Christoph Klade and Pencho Georgiev and Dorota Krochmalczyk and Liana Gercheva-kyuchukova and Miklos Egyed and Viktor Rossiev and Petr Dulicek and Arpad Illes and Halyna Pylypenko and Lylia Sivcheva and Jiri Mayer and Vera Yablokova and Kurt Krejcy and Hasselbalch, {Hans C.} and Robert Kralovics and Jean-jacques Kiladjian",
year = "2020",
doi = "10.1097/HS9.0000000000000485",
language = "English",
volume = "4",
journal = "HemaSphere",
issn = "2572-9241",
publisher = "Lippincott, Williams & Wilkins",
number = "6",
}
RIS
TY - JOUR
T1 - Ropeginterferon Alfa-2b
T2 - Efficacy and Safety in Different Age Groups
AU - Gisslinger, Heinz
AU - Klade, Christoph
AU - Georgiev, Pencho
AU - Krochmalczyk, Dorota
AU - Gercheva-kyuchukova, Liana
AU - Egyed, Miklos
AU - Rossiev, Viktor
AU - Dulicek, Petr
AU - Illes, Arpad
AU - Pylypenko, Halyna
AU - Sivcheva, Lylia
AU - Mayer, Jiri
AU - Yablokova, Vera
AU - Krejcy, Kurt
AU - Hasselbalch, Hans C.
AU - Kralovics, Robert
AU - Kiladjian, Jean-jacques
PY - 2020
Y1 - 2020
U2 - 10.1097/HS9.0000000000000485
DO - 10.1097/HS9.0000000000000485
M3 - Journal article
C2 - 33134869
VL - 4
JO - HemaSphere
JF - HemaSphere
SN - 2572-9241
IS - 6
M1 - e485
ER -
